Coral Springs, FLORIDA2 Active Studies

Parkinsons Disease Clinical Trials in Coral Springs, FLORIDA

Find 2 actively recruiting parkinsons disease clinical trials in Coral Springs, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
162
Enrolling

Recruiting Parkinsons Disease Studies in Coral Springs

About Parkinsons Disease Clinical Trials in Coral Springs

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 2 parkinsons disease clinical trials recruiting participants in Coral Springs, FLORIDA. These studies are seeking a combined 162 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., Ventus Therapeutics U.S., Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Coral Springs — FAQ

Are there parkinsons disease clinical trials in Coral Springs?

Yes, there are 2 parkinsons disease clinical trials currently recruiting in Coral Springs, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Coral Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Coral Springs research site will contact you about next steps.

Are clinical trials in Coral Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Coral Springs studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 2 active trials in Coral Springs are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated March 2, 2026 from ClinicalTrials.gov